SR

Suneethi Raveendran Raja

Active Director Director DIN 08930915
DIN 08930915 First appointment Dec 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Suneethi Raveendran Raja

Data last updated:

Suneethi Raveendran Raja is a Director at Narniat Pharmaceuticals And Chemicals Pvt Ltd (since 2020). The company operates in Pharma.

DIN 08930915
Primary Designation Director
Industry Pharma
First Appointment 09 Dec 2020
Oldest Company Age 55 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Dec 20201971Active

Directorship timeline

Open interactive timeline →
Narniat Pharmaceuticals And Chemicals Pvt Ltd
Premium access

Shareholding and investment profile for Suneethi Raveendran Raja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suneethi Raveendran Raja

Suneethi Raveendran Raja currently holds 1 directorship: Narniat Pharmaceuticals And Chemicals Pvt Ltd (Director, since 09 Dec 2020).

Suneethi Raveendran Raja was first appointed on 09 Dec 2020 as Director at Narniat Pharmaceuticals And Chemicals Pvt Ltd.

The current boards of Suneethi Raveendran Raja's companies include Puthiva Kovilakath Keralavarma (Narniat Pharmaceuticals And Chemicals Pvt Ltd), Rama Varma Jayasree Varma (Narniat Pharmaceuticals And Chemicals Pvt Ltd), Sujithvarma (Narniat Pharmaceuticals And Chemicals Pvt Ltd).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available